Quanex Building Products (NX) Financials

$17.51 -0.08 (-0.46%)

As of 03:10 PM Eastern

Annual Income Statements for Quanex Building Products

This table shows Quanex Building Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015	10/31/2014
Net Income / (Loss) Attributable to Common Shareholders	33	83	88	57	38	-47	27	19	-1.86	16	29
Consolidated Net Income / (Loss)	33	83	88	57	38	-47	27	19	-1.86	16	29
Net Income / (Loss) Continuing Operations	42	97	110	57	38	-47	27	19	-1.86	16	8.34
Total Pre-Tax Income	42	97	110	80	50	-36	26	26	-5.62	23	14
Total Operating Income	55	111	111	82	55	-26	36	34	36	25	14
Total Gross Profit	306	278	268	241	193	199	193	194	218	146	131
Total Revenue	1,278	1,131	1,222	1,072	852	894	890	867	928	646	595
Operating Revenue	1,278	1,131	1,222	1,072	852	894	890	867	928	646	595
Total Cost of Revenue	972	853	953	832	659	694	697	672	711	499	465
Operating Cost of Revenue	972	853	953	832	659	694	697	672	711	499	465
Total Operating Expenses	251	167	157	159	138	226	157	160	181	122	117
Selling, General & Admin Expense	190	124	117	116	90	101	104	98	115	87	82
Depreciation Expense	60	43	40	43	47	50	52	57	53	35	34
Restructuring Charge	0.00	0.00	0.00	0.04	0.62	0.37	1.49	4.55	0.53	0.00	0.00
Total Other Income / (Expense), net	-13	-14	-1.52	-1.78	-4.97	-9.53	-9.94	-8.44	-42	-1.52	-0.47
Interest Expense	21	8.14	2.56	2.53	5.25	9.64	11	9.60	36	0.99	0.56
Other Income / (Expense), net	7.85	-5.52	1.04	0.75	0.28	0.12	1.16	1.16	-5.48	-0.53	0.09
Other Adjustments to Consolidated Net Income / (Loss)	-9.02	-15	-21	-	-	-	-	-	-	-	-
Basic Earnings per Share	$0.91	$2.51	$2.67	$1.72	$1.18	($1.42)	$0.77	$0.55	($0.05)	$0.47	$0.79
Weighted Average Basic Shares Outstanding	36.42M	32.82M	33.05M	33.19M	32.69M	32.96M	34.70M	34.23M	33.88M	33.99M	37.13M
Diluted Earnings per Share	$0.90	$2.50	$2.66	$1.70	$1.17	($1.42)	$0.76	$0.54	($0.05)	$0.47	$0.78
Weighted Average Diluted Shares Outstanding	36.65M	33.03M	33.21M	33.50M	32.82M	32.96M	35.03M	34.84M	33.88M	34.50M	37.68M
Weighted Average Basic & Diluted Shares Outstanding	47.26M	33.00M	33.13M	66.50M	65.66M	33.02M	34.60M	34M	-2.40M	24.80M	58.50M
Cash Dividends to Common per Share	$0.32	$0.32	$0.32	$0.32	$0.32	$0.32	$0.20	$0.16	$0.16	$0.16	$0.16

This table shows Quanex Building Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-15	-14	25	15	6.25	27	32	22	1.91	25	26
Consolidated Net Income / (Loss)	-15	-14	25	15	6.25	27	32	22	1.91	25	26
Net Income / (Loss) Continuing Operations	-20	-13	32	15	7.89	37	36	21	2.36	30	34
Total Pre-Tax Income	-20	-18	32	20	6.85	32	36	27	2.36	28	34
Total Operating Income	-6.98	2.83	23	21	7.92	39	37	29	4.40	29	34
Total Gross Profit	92	117	71	66	51	80	79	67	52	67	73
Total Revenue	400	492	280	266	239	295	300	274	262	308	324
Operating Revenue	400	492	280	266	239	295	300	274	262	308	324
Total Cost of Revenue	308	375	209	200	188	215	221	206	210	240	251
Operating Cost of Revenue	308	375	209	200	188	215	221	206	210	240	251
Total Operating Expenses	99	114	47	46	44	41	41	38	47	39	39
Selling, General & Admin Expense	67	87	37	35	32	29	31	27	37	29	29
Depreciation Expense	25	27	11	11	11	11	11	10	11	9.56	9.73
Restructuring Charge	7.90	-	-	-	0.00	-	-	-	-	-	-
Total Other Income / (Expense), net	-13	-20	8.60	-0.95	-1.07	-7.70	-1.67	-2.24	-2.04	-0.52	-0.33
Interest Expense	14	18	0.88	0.95	1.07	1.57	2.07	2.24	2.26	0.71	0.72
Other Income / (Expense), net	1.23	-	9.47	-	-	-	0.40	-	0.22	-	0.40
Income Tax Expense	-5.05	-	6.69	4.31	1.64	-	4.10	5.55	0.45	-	-
Basic Earnings per Share	($0.32)	($0.52)	$0.77	$0.47	$0.19	$0.83	$0.97	$0.65	$0.06	$0.74	$0.79
Weighted Average Basic Shares Outstanding	47.02M	36.42M	32.88M	32.87M	32.83M	32.82M	32.72M	32.86M	32.95M	33.05M	33.00M
Diluted Earnings per Share	($0.32)	($0.52)	$0.77	$0.46	$0.19	$0.83	$0.96	$0.65	$0.06	$0.74	$0.78
Weighted Average Diluted Shares Outstanding	47.02M	36.65M	33.11M	33.10M	33.04M	33.03M	32.92M	33.02M	33.14M	33.21M	33.17M
Weighted Average Basic & Diluted Shares Outstanding	47.23M	47.26M	47.25M	33.11M	33.10M	33.00M	32.99M	32.95M	33.24M	33.13M	66.26M
Cash Dividends to Common per Share	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08

This table details how cash moves in and out of Quanex Building Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015	10/31/2014
Net Change in Cash & Equivalents	45	3.38	15	-12	21	1.87	12	-8.07	2.40	-97	71
Net Cash From Operating Activities	89	147	98	79	101	96	105	80	87	67	21
Net Cash From Continuing Operating Activities	89	147	98	79	101	96	105	80	87	67	21
Net Income / (Loss) Continuing Operations	33	83	88	57	38	-47	27	19	-1.86	16	29
Consolidated Net Income / (Loss)	33	83	88	57	38	-47	27	19	-1.86	16	29
Depreciation Expense	60	43	40	43	47	50	52	57	53	35	37
Non-Cash Adjustments To Reconcile Net Income	-5.31	2.80	2.40	5.01	0.88	77	1.73	6.72	19	3.44	-37
Changes in Operating Assets and Liabilities, net	0.73	19	-33	-26	14	16	23	-3.01	1.36	12	-8.70
Net Cash From Investing Activities	-421	-128	-33	-19	-25	-24	-26	-33	-282	-160	74
Net Cash From Continuing Investing Activities	-421	-128	-33	-19	-25	-24	-26	-33	-282	-160	74
Purchase of Property, Plant & Equipment	-37	-37	-33	-24	-26	-25	-26	-35	-37	-30	-34
Acquisitions	-399	-91	0.00	0.00	-	-	-	-	-246	-132	-5.16
Sale of Property, Plant & Equipment	15	0.25	0.16	5.30	0.50	1.32	0.43	1.94	1.04	0.26	0.83
Net Cash From Financing Activities	385	-16	-46	-72	-55	-71	-66	-55	195	-4.58	-24
Net Cash From Continuing Financing Activities	385	-16	-46	-72	-55	-71	-66	-55	195	-4.58	-24
Repayment of Debt	-394	-103	-98	-66	-155	-138	-299	-102	-436	-69	-0.18
Repurchase of Common Equity	0.00	-5.59	-6.60	-11	-7.23	-9.55	-32	0.00	0.00	-53	-22
Payment of Dividends	-12	-11	-11	-11	-11	-11	-7.02	-5.52	-5.47	-5.52	-5.99
Issuance of Debt	785	102	71	0.00	115	84	269	54	635	117	0.09
Other Financing Activities, net	5.89	0.65	-0.72	16	3.17	2.96	3.79	-1.52	2.61	5.17	3.90
Effect of Exchange Rate Changes	-8.85	0.92	-4.09	0.42	0.30	0.32	-1.19	-0.09	1.72	0.38	0.21

This table details how cash moves in and out of Quanex Building Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	-48	9.03	38	12	-14	-15	30	0.44	-12	5.06	11
Net Cash From Operating Activities	-13	5.48	46	33	3.85	44	64	35	3.14	48	52
Net Cash From Continuing Operating Activities	-13	5.48	46	33	3.85	44	64	35	3.14	48	52
Net Income / (Loss) Continuing Operations	-15	-14	25	15	6.25	27	32	22	1.91	25	26
Consolidated Net Income / (Loss)	-15	-14	25	15	6.25	27	32	22	1.91	25	26
Depreciation Expense	25	27	11	11	11	11	11	10	11	9.56	9.73
Non-Cash Adjustments To Reconcile Net Income	7.08	0.85	-7.68	-0.85	3.51	-1.45	1.87	0.19	2.19	-1.95	1.70
Changes in Operating Assets and Liabilities, net	-29	-8.78	18	7.67	-17	7.37	20	3.17	-12	16	14
Net Cash From Investing Activities	-11	-397	-6.23	-7.54	-9.55	-15	-7.29	-6.79	-99	-14	-5.61
Net Cash From Continuing Investing Activities	-11	-397	-6.23	-7.54	-9.55	-15	-7.29	-6.79	-99	-14	-5.61
Purchase of Property, Plant & Equipment	-12	-14	-6.25	-7.60	-9.58	-15	-7.38	-7.49	-7.58	-14	-5.70
Acquisitions	0.00	-399	-	-	0.00	-	-	0.70	-92	-	-
Sale of Property, Plant & Equipment	0.17	15	0.02	0.06	0.03	0.07	0.08	0.00	0.10	0.03	0.10
Net Cash From Financing Activities	-22	411	-3.57	-13	-9.12	-43	-28	-29	83	-28	-34
Net Cash From Continuing Financing Activities	-22	411	-3.57	-13	-9.12	-43	-28	-29	83	-28	-34
Repayment of Debt	-58	-377	-0.94	-10	-5.68	-41	-26	-21	-16	-25	-27
Repurchase of Common Equity	-3.70	-	-	-	0.00	-	-	-5.59	0.00	-	-5.03
Payment of Dividends	-3.81	-4.03	-2.65	-2.65	-2.65	-2.69	-2.63	-2.66	-2.66	-2.68	-2.66
Issuance of Debt	45	785	-	-	0.00	-	-	-	102	-	-
Other Financing Activities, net	-1.19	6.51	0.02	0.15	-0.79	0.46	0.65	-0.02	-0.45	0.19	0.33
Effect of Exchange Rate Changes	-1.59	-9.79	1.23	-1.05	0.76	-	-	0.91	1.00	-1.50	-0.56

This table presents Quanex Building Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015	10/31/2014
Total Assets	2,320	831	725	717	692	645	743	774	780	566	517
Total Current Assets	611	274	281	249	207	190	191	192	204	158	260
Cash & Equivalents	98	58	55	40	52	31	29	17	26	23	120
Restricted Cash	5.25	0.00	-	-	-	-	-	-	-	-	-
Accounts Receivable	198	97	96	108	88	83	84	79	84	64	55
Inventories, net	276	98	121	93	61	67	71	88	84	63	57
Prepaid Expenses	29	12	8.66	8.15	6.22	9.35	7.30	7.41	10	7.99	6.05
Current Deferred & Refundable Income Taxes	5.94	8.30	0.00	-	-	-	-	-	-	-	21
Plant, Property, & Equipment, net	402	251	180	179	184	194	201	211	198	141	109
Total Noncurrent Assets	1,306	307	264	290	300	261	351	371	378	267	147
Goodwill	575	183	138	149	146	146	220	222	217	130	71
Intangible Assets	598	74	65	82	93	107	122	140	154	121	70
Noncurrent Deferred & Refundable Income Taxes	3.85	0.00	-	-	-	-	-	-	-	8.78	1.55
Other Noncurrent Operating Assets	130	50	61	58	61	8.32	9.26	8.98	6.67	7.26	4.96
Total Liabilities & Shareholders' Equity	2,320	831	725	717	692	645	743	774	780	566	517
Total Liabilities	1,309	286	260	298	336	315	348	367	413	170	96
Total Current Liabilities	273	135	140	158	130	110	102	106	114	88	74
Short-Term Debt	26	2.37	1.05	0.85	0.69	0.75	1.22	21	11	2.36	0.20
Accounts Payable	124	74	78	87	77	64	52	44	48	48	41
Accrued Expenses	104	50	52	56	38	39	46	39	55	37	32
Current Deferred & Payable Income Tax Liabilities	6.62	0.38	1.05	6.04	6.47	6.18	2.78	2.19	0.73	0.75	0.11
Other Current Liabilities	12	7.22	7.73	8.20	7.46	0.00	-	-	-	-	-
Total Noncurrent Liabilities	1,036	151	120	140	206	205	246	261	298	82	22
Long-Term Debt	737	66	30	52	117	156	209	218	259	54	0.59
Noncurrent Deferred & Payable Income Tax Liabilities	162	29	24	23	20	20	18	23	19	0.56	4.63
Other Noncurrent Operating Liabilities	137	55	63	59	58	16	14	15	12	22	12
Commitments & Contingencies	0.00	-	-	-	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	1,011	546	465	420	356	330	395	407	368	395	421
Total Preferred & Common Equity	1,011	546	465	420	356	330	395	407	368	395	421
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,011	546	465	420	356	330	395	407	368	395	421
Common Stock	702	252	252	255	254	255	255	256	255	251	250
Retained Earnings	430	409	337	260	214	186	244	226	214	222	202
Treasury Stock	-75	-78	-76	-73	-79	-77	-73	-50	-62	-68	-26
Accumulated Other Comprehensive Income / (Loss)	-46	-38	-49	-22	-33	-34	-31	-25	-39	-10	-5.71

This table presents Quanex Building Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	1/31/2025	7/31/2024	4/30/2024	1/31/2024	7/31/2023	4/30/2023	1/31/2023	7/31/2022
Total Assets	2,220	872	837	813	848	822	827	744
Total Current Assets	548	301	264	253	288	264	267	306
Cash & Equivalents	50	94	56	44	73	43	43	50
Restricted Cash	5.49	-	-	-	-	-	-	-
Accounts Receivable	164	88	87	80	96	94	85	109
Inventories, net	281	99	101	107	105	114	128	138
Prepaid Expenses	42	19	13	13	13	12	11	8.65
Current Deferred & Refundable Income Taxes	5.28	1.45	6.05	7.64	-	-	-	-
Plant, Property, & Equipment, net	391	252	253	254	246	243	242	175
Total Noncurrent Assets	1,282	319	321	307	314	316	318	262
Goodwill	570	186	184	185	186	185	185	141
Intangible Assets	580	67	69	72	79	81	83	70
Noncurrent Deferred & Refundable Income Taxes	3.71	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	128	66	68	49	49	50	50	51
Total Liabilities & Shareholders' Equity	2,220	872	837	813	848	822	827	744
Total Liabilities	1,248	278	271	258	322	329	351	293
Total Current Liabilities	229	128	119	111	135	119	120	159
Short-Term Debt	26	2.69	2.63	2.50	2.28	2.11	2.00	1.07
Accounts Payable	108	64	61	55	71	64	63	85
Accrued Expenses	81	55	49	46	54	45	46	51
Current Deferred & Payable Income Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	1.62	14
Other Current Liabilities	13	6.44	6.43	7.37	7.39	7.40	7.21	7.97
Total Noncurrent Liabilities	1,020	150	153	147	186	211	231	135
Long-Term Debt	725	51	52	62	107	132	152	55
Noncurrent Deferred & Payable Income Tax Liabilities	163	27	29	31	24	23	23	21
Other Noncurrent Operating Liabilities	132	72	72	55	56	55	56	54
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	972	594	566	555	526	493	476	450
Total Preferred & Common Equity	972	594	566	555	526	493	476	450
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	972	594	566	555	526	493	476	450
Common Stock	698	251	250	249	251	251	250	252
Retained Earnings	412	448	426	413	385	356	337	315
Treasury Stock	-75	-75	-75	-75	-78	-79	-73	-76
Accumulated Other Comprehensive Income / (Loss)	-62	-30	-35	-32	-32	-35	-38	-41

This table displays calculated financial ratios and metrics derived from Quanex Building Products' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015	10/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.03%	-7.44%	13.93%	25.90%	-4.73%	0.46%	2.68%	-6.64%	43.79%	8.42%	7.30%
EBITDA Growth	-16.92%	-2.88%	21.60%	21.97%	341.56%	-74.06%	-3.08%	-7.45%	68.52%	15.77%	22.52%
EBIT Growth	-40.41%	-6.36%	35.94%	48.75%	311.11%	-171.39%	5.00%	13.68%	27.87%	68.04%	177.04%
NOPAT Growth	-50.47%	-0.52%	91.06%	37.70%	328.64%	-150.26%	48.04%	-2.30%	52.92%	93.00%	165.44%
Net Income Growth	-59.93%	-6.61%	55.03%	48.02%	182.38%	-275.99%	42.12%	1,105.00%	-111.55%	-44.95%	349.80%
EPS Growth	-64.00%	-6.02%	56.47%	45.30%	182.39%	-286.84%	40.74%	1,180.00%	-110.64%	-39.74%	343.75%
Operating Cash Flow Growth	-39.61%	50.11%	24.66%	-22.03%	4.59%	-7.88%	31.13%	-8.66%	30.19%	222.88%	-52.26%
Free Cash Flow Firm Growth	-22,154.63%	-104.60%	119.61%	-38.95%	-24.15%	14.57%	1,027.44%	104.98%	-43.29%	-2,795.79%	-90.26%
Invested Capital Growth	200.55%	26.22%	1.79%	2.63%	-7.65%	-20.86%	-8.28%	2.78%	42.85%	42.14%	1.53%
Revenue Q/Q Growth	18.19%	-1.05%	1.31%	3.51%	1.80%	-0.41%	1.27%	-1.84%	6.14%	5.15%	14.76%
EBITDA Q/Q Growth	-9.35%	5.00%	1.25%	-1.55%	97.68%	-60.35%	-3.37%	12.43%	-6.13%	27.97%	-16.14%
EBIT Q/Q Growth	-31.50%	5.42%	2.29%	-0.95%	1,396.36%	-392.57%	-7.41%	38.89%	-23.30%	78.47%	164.07%
NOPAT Q/Q Growth	-40.08%	10.95%	1.35%	-29.49%	1,527.77%	-393.86%	-7.53%	13.50%	18.26%	85.24%	197.21%
Net Income Q/Q Growth	-55.54%	3.40%	4.46%	-2.15%	363.60%	-415.50%	-13.13%	39.61%	-170.07%	44.90%	26.71%
EPS Q/Q Growth	-60.00%	3.73%	4.72%	-2.86%	365.91%	-389.66%	-14.61%	38.46%	-171.43%	42.42%	30.00%
Operating Cash Flow Q/Q Growth	-30.52%	-2.40%	20.93%	-21.94%	-11.50%	11.81%	27.94%	-5.86%	1.48%	63.23%	-57.68%
Free Cash Flow Firm Q/Q Growth	-1,165.91%	17.99%	17.41%	-52.49%	-17.55%	20.11%	48.22%	-66.58%	6.65%	16.50%	-95.47%
Invested Capital Q/Q Growth	201.42%	-1.13%	-3.55%	-0.54%	-6.66%	-15.88%	-7.14%	-1.94%	-4.84%	-5.26%	-3.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.92%	24.55%	21.98%	22.44%	22.64%	22.31%	21.66%	22.40%	23.44%	22.68%	21.97%
EBITDA Margin	9.63%	13.09%	12.48%	11.69%	12.07%	2.60%	10.09%	10.69%	10.78%	9.20%	8.61%
Operating Margin	4.29%	9.79%	9.11%	7.64%	6.49%	-2.96%	4.01%	3.92%	3.92%	3.82%	2.40%
EBIT Margin	4.90%	9.30%	9.20%	7.71%	6.52%	-2.94%	4.14%	4.05%	3.33%	3.74%	2.41%
Profit (Net Income) Margin	2.59%	7.30%	7.23%	5.31%	4.52%	-5.23%	2.98%	2.16%	-0.20%	2.49%	4.91%
Tax Burden Percent	78.56%	85.01%	80.48%	71.14%	76.53%	129.97%	103.11%	73.26%	33.05%	69.51%	211.75%
Interest Burden Percent	67.14%	92.26%	97.72%	96.94%	90.56%	136.65%	69.88%	72.66%	-18.22%	95.90%	96.09%
Effective Tax Rate	0.00%	0.00%	0.00%	28.86%	23.47%	0.00%	-3.11%	26.74%	0.00%	32.56%	39.61%
Return on Invested Capital (ROIC)	4.92%	22.22%	25.49%	13.64%	9.63%	-3.58%	6.11%	4.01%	4.89%	4.56%	2.88%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.57%	422.42%	423.15%	10.42%	5.68%	-21.92%	1.02%	1.36%	-14.82%	5.83%	-14.37%
Return on Net Nonoperating Assets (RNNOA)	-0.68%	-5.89%	-5.52%	1.06%	1.59%	-9.30%	0.52%	0.82%	-5.38%	-0.62%	4.10%
Return on Equity (ROE)	4.25%	16.33%	19.97%	14.69%	11.22%	-12.88%	6.62%	4.82%	-0.49%	3.94%	6.98%
Cash Return on Invested Capital (CROIC)	-95.21%	-0.96%	23.72%	11.04%	17.59%	19.70%	14.74%	1.27%	-30.40%	-30.24%	1.37%
Operating Return on Assets (OROA)	3.98%	13.52%	15.58%	11.73%	8.31%	-3.79%	4.86%	4.52%	4.59%	4.46%	2.64%
Return on Assets (ROA)	2.10%	10.61%	12.25%	8.09%	5.76%	-6.73%	3.50%	2.40%	-0.28%	2.97%	5.37%
Return on Common Equity (ROCE)	4.25%	16.33%	19.97%	14.69%	11.22%	-12.88%	6.62%	4.82%	-0.49%	3.94%	6.98%
Return on Equity Simple (ROE_SIMPLE)	3.27%	15.12%	19.00%	13.57%	10.82%	-14.15%	6.72%	4.59%	-0.51%	4.07%	6.95%
Net Operating Profit after Tax (NOPAT)	55	111	111	58	42	-18	37	25	25	17	8.62
NOPAT Margin	4.29%	9.79%	9.11%	5.43%	4.97%	-2.07%	4.14%	2.87%	2.74%	2.58%	1.45%
Net Nonoperating Expense Percent (NNEP)	6.50%	-400.20%	-397.66%	3.21%	3.96%	18.34%	5.08%	2.65%	19.72%	-1.26%	17.25%
Return On Investment Capital (ROIC_SIMPLE)	3.09%	18.02%	22.46%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	76.08%	75.45%	78.02%	77.56%	77.36%	77.69%	78.34%	77.60%	76.56%	77.32%	78.03%
SG&A Expenses to Revenue	14.91%	10.96%	9.59%	10.82%	10.53%	11.33%	11.66%	11.32%	12.38%	13.41%	13.80%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.63%	14.76%	12.87%	14.81%	16.15%	25.27%	17.65%	18.48%	19.52%	18.86%	19.57%
Earnings before Interest and Taxes (EBIT)	63	105	112	83	56	-26	37	35	31	24	14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	123	148	152	125	103	23	90	93	100	59	51
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.35	1.60	1.54	1.60	1.60	1.81	1.21	1.70	1.36	1.44	1.58
Price to Tangible Book Value (P/TBV)	0.00	3.03	2.73	3.56	4.88	7.71	8.87	15.38	0.00	3.94	2.37
Price to Revenue (P/Rev)	1.07	0.77	0.59	0.63	0.67	0.67	0.54	0.80	0.54	0.88	1.11
Price to Earnings (P/E)	41.42	10.59	8.09	11.77	14.77	0.00	17.94	36.93	0.00	35.39	22.68
Dividend Yield	1.10%	1.21%	1.48%	1.60%	1.85%	1.78%	1.48%	0.81%	1.09%	0.95%	0.91%
Earnings Yield	2.41%	9.44%	12.36%	8.50%	6.77%	0.00%	5.57%	2.71%	0.00%	2.83%	4.41%
Enterprise Value to Invested Capital (EV/IC)	1.21	1.59	1.57	1.58	1.51	1.58	1.14	1.45	1.22	1.41	1.80
Enterprise Value to Revenue (EV/Rev)	1.59	0.78	0.57	0.64	0.75	0.81	0.74	1.05	0.80	0.93	0.91
Enterprise Value to EBITDA (EV/EBITDA)	16.50	5.97	4.53	5.45	6.17	31.05	7.33	9.85	7.44	10.15	10.60
Enterprise Value to EBIT (EV/EBIT)	32.38	8.41	6.15	8.27	11.42	0.00	17.85	25.98	24.12	24.95	37.83
Enterprise Value to NOPAT (EV/NOPAT)	37.01	7.99	6.20	11.73	15.00	0.00	17.87	36.68	29.27	36.21	63.04
Enterprise Value to Operating Cash Flow (EV/OCF)	22.85	6.01	7.05	8.70	6.29	7.50	6.29	11.43	8.53	8.98	26.16
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	6.67	14.50	8.22	7.10	7.40	115.72	0.00	0.00	132.80
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.75	0.13	0.07	0.13	0.33	0.48	0.53	0.59	0.73	0.14	0.00
Long-Term Debt to Equity	0.73	0.12	0.06	0.12	0.33	0.47	0.53	0.54	0.70	0.14	0.00
Financial Leverage	0.43	-0.01	-0.01	0.10	0.28	0.42	0.50	0.60	0.36	-0.11	-0.29
Leverage Ratio	2.02	1.54	1.63	1.82	1.95	1.91	1.89	2.01	1.76	1.33	1.30
Compound Leverage Factor	1.36	1.42	1.59	1.76	1.76	2.62	1.32	1.46	-0.32	1.27	1.25
Debt to Total Capital	43.01%	11.20%	6.19%	11.20%	24.82%	32.25%	34.76%	37.05%	42.29%	12.43%	0.19%
Short-Term Debt to Total Capital	1.45%	0.39%	0.21%	0.18%	0.15%	0.15%	0.20%	3.29%	1.65%	0.52%	0.05%
Long-Term Debt to Total Capital	41.56%	10.81%	5.98%	11.02%	24.67%	32.10%	34.56%	33.76%	40.64%	11.91%	0.14%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	56.99%	88.80%	93.81%	88.80%	75.18%	67.75%	65.24%	62.95%	57.71%	87.57%	99.81%
Debt to EBITDA	6.20	0.46	0.20	0.42	1.14	6.75	2.35	2.59	2.69	0.95	0.02
Net Debt to EBITDA	5.37	0.07	-0.16	0.10	0.64	5.43	2.02	2.40	2.44	0.56	-2.33
Long-Term Debt to EBITDA	5.99	0.45	0.19	0.42	1.14	6.72	2.33	2.36	2.59	0.91	0.01
Debt to NOPAT	13.92	0.62	0.28	0.91	2.78	-8.50	5.72	9.63	10.59	3.37	0.09
Net Debt to NOPAT	12.04	0.09	-0.22	0.22	1.56	-6.83	4.93	8.93	9.59	1.98	-13.87
Long-Term Debt to NOPAT	13.45	0.60	0.27	0.89	2.76	-8.46	5.69	8.78	10.18	3.23	0.07
Altman Z-Score	1.70	4.50	4.73	3.89	3.08	2.94	2.78	2.94	2.57	3.99	6.36
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.24	2.03	2.01	1.58	1.59	1.73	1.87	1.80	1.79	1.79	3.51
Quick Ratio	1.08	1.16	1.08	0.94	1.07	1.04	1.10	0.91	0.96	0.99	2.36
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,060	-4.76	104	47	77	102	89	7.88	-158	-110	4.09
Operating Cash Flow to CapEx	402.96%	395.97%	297.21%	420.08%	399.60%	409.07%	401.55%	244.52%	241.28%	225.75%	63.06%
Free Cash Flow to Firm to Interest Expense	-51.47	-0.59	40.46	18.63	14.72	10.56	8.00	0.82	-4.33	-111.34	7.28
Operating Cash Flow to Interest Expense	4.31	18.07	38.28	31.06	19.22	9.99	9.42	8.31	2.39	67.70	36.97
Operating Cash Flow Less CapEx to Interest Expense	3.24	13.51	25.40	23.67	14.41	7.55	7.08	4.91	1.40	37.71	-21.65
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.81	1.45	1.69	1.52	1.27	1.29	1.17	1.12	1.38	1.19	1.09
Accounts Receivable Turnover	8.66	11.70	11.96	10.91	9.95	10.71	10.89	10.63	12.57	10.82	10.39
Inventory Turnover	5.21	7.80	8.93	10.82	10.27	10.07	8.81	7.83	9.64	8.29	9.38
Fixed Asset Turnover	3.91	5.25	6.80	5.91	4.51	4.53	4.31	4.23	5.47	5.16	5.51
Accounts Payable Turnover	9.78	11.20	11.57	10.13	9.35	11.97	14.44	14.63	14.87	11.18	11.76
Days Sales Outstanding (DSO)	42.13	31.21	30.53	33.46	36.70	34.09	33.52	34.34	29.04	33.72	35.14
Days Inventory Outstanding (DIO)	70.11	46.82	40.87	33.74	35.56	36.24	41.44	46.64	37.84	44.02	38.90
Days Payable Outstanding (DPO)	37.31	32.58	31.53	36.02	39.05	30.48	25.28	24.95	24.54	32.64	31.04
Cash Conversion Cycle (CCC)	74.93	45.45	39.86	31.18	33.21	39.84	49.68	56.03	42.35	45.10	43.01
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,671	556	440	433	422	456	577	629	612	428	301
Invested Capital Turnover	1.15	2.27	2.80	2.51	1.94	1.73	1.48	1.40	1.78	1.77	1.99
Increase / (Decrease) in Invested Capital	1,115	115	7.76	11	-35	-120	-52	17	184	127	4.53
Enterprise Value (EV)	2,029	884	690	683	634	723	658	912	745	602	544
Market Capitalization	1,369	874	715	670	569	597	476	690	501	569	663
Book Value per Share	$21.39	$16.54	$14.03	$12.52	$10.84	$9.96	$11.24	$11.71	$10.75	$11.65	$11.21
Tangible Book Value per Share	($3.43)	$8.75	$7.91	$5.61	$3.55	$2.33	$1.53	$1.29	($0.10)	$4.27	$7.47
Total Capital	1,774	614	496	473	473	487	606	646	637	451	422
Total Debt	763	69	31	53	117	157	211	239	270	56	0.79
Total Long-Term Debt	737	66	30	52	117	156	209	218	259	54	0.59
Net Debt	660	10	-24	13	66	126	182	222	244	33	-120
Capital Expenditures (CapEx)	22	37	33	19	25	24	26	33	36	30	33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	261	83	87	52	26	50	61	89	75	49	66
Debt-free Net Working Capital (DFNWC)	364	141	142	92	78	81	90	107	100	72	186
Net Working Capital (NWC)	338	139	141	91	77	81	89	85	90	70	186
Net Nonoperating Expense (NNE)	22	28	23	1.26	3.80	28	10	6.18	27	0.55	-21
Net Nonoperating Obligations (NNO)	660	10	-24	13	66	126	182	222	244	33	-120
Total Depreciation and Amortization (D&A)	60	43	40	43	47	50	53	57	69	35	37
Debt-free, Cash-free Net Working Capital to Revenue	20.44%	7.33%	7.10%	4.83%	3.07%	5.64%	6.84%	10.29%	8.06%	7.62%	11.08%
Debt-free Net Working Capital to Revenue	28.50%	12.50%	11.61%	8.57%	9.13%	9.10%	10.10%	12.30%	10.81%	11.21%	31.30%
Net Working Capital to Revenue	26.48%	12.29%	11.53%	8.49%	9.05%	9.01%	9.97%	9.85%	9.68%	10.84%	31.27%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.91	$2.51	$0.00	$1.72	$1.18	($1.42)	$0.76	$0.55	($0.05)	$0.47	$0.79
Adjusted Weighted Average Basic Shares Outstanding	36.42M	32.82M	0.00	33.19M	32.69M	32.96M	34.70M	34.23M	33.88M	33.99M	37.13M
Adjusted Diluted Earnings per Share	$0.90	$2.50	$0.00	$1.70	$1.17	($1.42)	$0.75	$0.54	($0.05)	$0.47	$0.78
Adjusted Weighted Average Diluted Shares Outstanding	36.65M	33.03M	0.00	33.50M	32.82M	32.96M	35.03M	34.84M	33.88M	34.50M	37.68M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.26M	33.00M	0.00	66.50M	65.66M	33.02M	33.50M	34.85M	34.20M	33.97M	36.14M
Normalized Net Operating Profit after Tax (NOPAT)	38	77	78	58	43	34	26	28	35	17	8.93
Normalized NOPAT Margin	3.00%	6.85%	6.38%	5.44%	5.02%	3.80%	2.93%	3.25%	3.73%	2.58%	1.50%
Pre Tax Income Margin	3.29%	8.58%	8.99%	7.47%	5.91%	-4.02%	2.89%	2.94%	-0.61%	3.59%	2.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.04	12.93	43.89	32.66	10.59	-2.73	3.32	3.66	0.85	24.36	25.57
NOPAT to Interest Expense	2.66	13.61	43.49	23.02	8.06	-1.92	3.32	2.59	0.70	16.79	15.34
EBIT Less CapEx to Interest Expense	1.97	8.36	31.01	25.26	5.78	-5.17	0.97	0.26	-0.15	-5.62	-33.06
NOPAT Less CapEx to Interest Expense	1.59	9.04	30.61	15.63	3.25	-4.36	0.97	-0.81	-0.29	-13.20	-43.28
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	36.21%	12.90%	12.00%	18.92%	27.36%	-22.78%	26.44%	29.52%	-294.24%	34.27%	20.50%
Augmented Payout Ratio	36.21%	19.67%	19.47%	38.54%	46.15%	-43.22%	147.08%	29.52%	-294.24%	361.86%	96.71%

This table displays calculated financial ratios and metrics derived from Quanex Building Products' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	67.27%	66.56%	-6.44%	-2.68%	-8.69%	-3.92%	-7.53%	-15.29%	-1.92%	5.40%	15.78%
EBITDA Growth	-0.41%	-40.51%	-9.48%	-20.76%	25.12%	32.97%	9.72%	-12.67%	-37.49%	1.96%	36.18%
EBIT Growth	-172.62%	-92.84%	-13.07%	-29.65%	71.33%	38.25%	9.97%	-16.19%	-67.29%	5.03%	58.31%
NOPAT Growth	-181.15%	-94.98%	-44.09%	-30.89%	69.14%	38.25%	-2.53%	-32.51%	-69.36%	5.45%	144.09%
Net Income Growth	-338.20%	-150.83%	-20.03%	-28.52%	227.34%	11.01%	22.35%	-18.89%	-83.01%	18.04%	89.40%
EPS Growth	-268.42%	-162.65%	-19.79%	-29.23%	216.67%	12.16%	23.08%	-18.75%	-82.35%	19.35%	90.24%
Operating Cash Flow Growth	-424.60%	-87.69%	-27.63%	-6.32%	22.93%	-7.52%	23.90%	78.68%	114.48%	54.43%	180.03%
Free Cash Flow Firm Growth	-6,327.76%	-1,364.93%	136.60%	141.05%	115.68%	-464.95%	-683.74%	-1,478.78%	-868.02%	30.18%	-59.41%
Invested Capital Growth	190.19%	200.55%	-1.41%	-3.31%	-1.98%	26.22%	23.12%	23.15%	24.67%	1.79%	4.97%
Revenue Q/Q Growth	-18.72%	75.56%	5.31%	11.31%	-19.07%	-1.38%	9.54%	4.44%	-14.83%	-5.09%	0.35%
EBITDA Q/Q Growth	-37.03%	-31.25%	39.13%	56.78%	-62.38%	4.61%	21.79%	161.09%	-60.02%	-13.68%	-3.07%
EBIT Q/Q Growth	-303.14%	-91.40%	59.50%	130.35%	-79.96%	4.32%	29.07%	534.84%	-83.83%	-17.03%	-1.63%
NOPAT Q/Q Growth	-346.57%	-89.32%	15.10%	103.56%	-84.76%	19.07%	42.26%	555.29%	-87.54%	-16.06%	-1.49%
Net Income Q/Q Growth	-6.96%	-154.90%	64.86%	146.07%	-77.18%	-13.62%	47.35%	1,026.87%	-92.26%	-4.79%	-2.32%
EPS Q/Q Growth	38.46%	-167.53%	67.39%	142.11%	-77.11%	-13.54%	47.69%	983.33%	-91.89%	-5.13%	-2.50%
Operating Cash Flow Q/Q Growth	-328.33%	-88.19%	40.18%	758.61%	-91.34%	-30.59%	81.46%	1,026.79%	-93.48%	-7.00%	161.68%
Free Cash Flow Firm Q/Q Growth	1.34%	-4,299.78%	-25.27%	81.57%	123.21%	-4.91%	16.17%	23.18%	-640.21%	67.81%	326.72%
Invested Capital Q/Q Growth	-0.18%	201.42%	-1.75%	-1.84%	3.39%	-1.13%	-3.65%	-0.48%	33.13%	-3.55%	-3.62%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.08%	23.78%	25.29%	24.88%	21.51%	27.08%	26.22%	24.55%	19.76%	21.94%	22.40%
EBITDA Margin	4.75%	6.13%	15.65%	11.84%	7.97%	17.16%	16.17%	14.55%	5.82%	12.40%	13.63%
Operating Margin	-1.74%	0.58%	8.36%	7.75%	3.31%	13.37%	12.50%	10.72%	1.68%	9.29%	10.50%
EBIT Margin	-1.44%	0.58%	11.74%	7.75%	3.31%	13.37%	12.64%	10.72%	1.76%	9.29%	10.63%
Profit (Net Income) Margin	-3.72%	-2.83%	9.04%	5.78%	2.61%	9.27%	10.58%	7.86%	0.73%	8.02%	8.00%
Tax Burden Percent	74.67%	79.35%	79.12%	78.09%	91.24%	86.04%	88.55%	79.49%	80.82%	87.94%	76.86%
Interest Burden Percent	346.76%	-619.72%	97.33%	95.42%	86.51%	80.57%	94.54%	92.25%	51.11%	98.18%	97.90%
Effective Tax Rate	0.00%	0.00%	20.88%	21.91%	23.97%	0.00%	11.45%	20.51%	19.18%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.57%	0.46%	12.81%	11.61%	4.80%	30.34%	24.83%	18.82%	3.13%	26.00%	28.41%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.36%	-4.28%	-364.00%	9.95%	5.16%	202.30%	17.93%	16.00%	1.02%	93.64%	-16.60%
Return on Net Nonoperating Assets (RNNOA)	-2.04%	-1.84%	1.17%	0.83%	0.65%	-2.82%	0.79%	2.21%	0.18%	-1.22%	-0.70%
Return on Equity (ROE)	-3.61%	-1.38%	13.99%	12.44%	5.45%	27.52%	25.62%	21.03%	3.31%	24.77%	27.71%
Cash Return on Invested Capital (CROIC)	-93.92%	-95.21%	17.81%	21.76%	21.68%	-0.96%	-1.14%	-2.53%	-6.53%	23.72%	19.78%
Operating Return on Assets (OROA)	-1.36%	0.47%	14.76%	10.28%	4.47%	19.43%	18.15%	16.02%	2.78%	15.74%	17.52%
Return on Assets (ROA)	-3.53%	-2.29%	11.37%	7.66%	3.53%	13.47%	15.19%	11.75%	1.15%	13.59%	13.18%
Return on Common Equity (ROCE)	-3.61%	-1.38%	13.99%	12.44%	5.45%	27.52%	25.62%	21.03%	3.31%	24.77%	27.71%
Return on Equity Simple (ROE_SIMPLE)	1.23%	0.00%	12.52%	14.26%	15.65%	0.00%	15.17%	15.02%	16.61%	0.00%	18.79%
Net Operating Profit after Tax (NOPAT)	-4.88	1.98	19	16	6.02	39	33	23	3.56	29	34
NOPAT Margin	-1.22%	0.40%	6.62%	6.05%	2.52%	13.37%	11.07%	8.53%	1.36%	9.29%	10.50%
Net Nonoperating Expense Percent (NNEP)	2.80%	4.74%	376.82%	1.66%	-0.35%	-171.96%	6.90%	2.81%	2.11%	-67.64%	45.01%
Return On Investment Capital (ROIC_SIMPLE)	-0.28%	0.11%	-	-	0.97%	6.43%	-	-	-	5.77%	-
Cost of Revenue to Revenue	76.92%	76.22%	74.71%	75.12%	78.49%	72.92%	73.78%	75.45%	80.24%	78.06%	77.60%
SG&A Expenses to Revenue	16.66%	17.66%	13.02%	13.04%	13.53%	9.92%	10.18%	10.01%	14.03%	9.54%	8.89%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.82%	23.21%	16.93%	17.13%	18.20%	13.71%	13.72%	13.83%	18.08%	12.65%	11.90%
Earnings before Interest and Taxes (EBIT)	-5.75	2.83	33	21	7.92	39	38	29	4.62	29	34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	19	30	44	32	19	51	48	40	15	38	44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.02	1.35	1.86	1.94	1.84	1.60	1.74	1.27	1.77	1.54	1.78
Price to Tangible Book Value (P/TBV)	0.00	0.00	3.24	3.50	3.42	3.03	3.52	2.77	4.06	2.73	3.34
Price to Revenue (P/Rev)	0.69	1.07	1.02	1.00	0.92	0.77	0.80	0.54	0.69	0.59	0.66
Price to Earnings (P/E)	83.23	41.42	14.87	13.59	11.73	10.59	11.50	8.46	10.67	8.09	9.46
Dividend Yield	1.52%	1.10%	0.96%	0.97%	1.04%	1.21%	1.15%	1.70%	1.26%	1.48%	1.33%
Earnings Yield	1.20%	2.41%	6.72%	7.36%	8.52%	9.44%	8.69%	11.81%	9.37%	12.36%	10.57%
Enterprise Value to Invested Capital (EV/IC)	1.01	1.21	1.92	1.94	1.81	1.59	1.70	1.23	1.63	1.57	1.77
Enterprise Value to Revenue (EV/Rev)	1.17	1.59	0.99	0.99	0.94	0.78	0.83	0.61	0.78	0.57	0.67
Enterprise Value to EBITDA (EV/EBITDA)	14.83	16.50	7.86	7.33	6.59	5.97	6.77	5.25	6.71	4.53	5.36
Enterprise Value to EBIT (EV/EBIT)	42.27	32.38	11.65	10.37	9.09	8.41	9.56	7.44	9.39	6.15	7.34
Enterprise Value to NOPAT (EV/NOPAT)	42.27	37.01	11.65	10.37	9.09	7.99	9.56	7.44	11.70	6.20	7.34
Enterprise Value to Operating Cash Flow (EV/OCF)	23.30	22.85	8.34	7.52	7.03	6.01	6.33	5.19	7.77	7.05	9.95
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	10.72	8.77	8.25	0.00	0.00	0.00	0.00	6.67	9.15
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.77	0.75	0.09	0.10	0.12	0.13	0.21	0.27	0.32	0.07	0.13
Long-Term Debt to Equity	0.75	0.73	0.09	0.09	0.11	0.12	0.20	0.27	0.32	0.06	0.12
Financial Leverage	0.47	0.43	0.00	0.08	0.13	-0.01	0.04	0.14	0.17	-0.01	0.04
Leverage Ratio	1.99	2.02	1.54	1.57	1.59	1.54	1.63	1.68	1.72	1.63	1.71
Compound Leverage Factor	6.89	-12.55	1.49	1.50	1.38	1.24	1.54	1.55	0.88	1.60	1.67
Debt to Total Capital	43.59%	43.01%	8.35%	8.73%	10.35%	11.20%	17.23%	21.41%	24.42%	6.19%	11.16%
Short-Term Debt to Total Capital	1.50%	1.45%	0.42%	0.42%	0.40%	0.39%	0.36%	0.34%	0.32%	0.21%	0.21%
Long-Term Debt to Total Capital	42.09%	41.56%	7.93%	8.31%	9.95%	10.81%	16.87%	21.08%	24.10%	5.98%	10.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	56.41%	56.99%	91.65%	91.27%	89.65%	88.80%	82.77%	78.59%	75.58%	93.81%	88.84%
Debt to EBITDA	6.60	6.20	0.40	0.36	0.41	0.46	0.78	0.98	1.08	0.20	0.38
Net Debt to EBITDA	6.11	5.37	-0.29	-0.01	0.12	0.07	0.26	0.66	0.78	-0.16	0.04
Long-Term Debt to EBITDA	6.37	5.99	0.38	0.35	0.39	0.45	0.76	0.97	1.07	0.19	0.37
Debt to NOPAT	18.81	13.92	0.59	0.51	0.56	0.62	1.10	1.39	1.89	0.28	0.51
Net Debt to NOPAT	17.42	12.04	-0.44	-0.02	0.17	0.09	0.36	0.94	1.36	-0.22	0.06
Long-Term Debt to NOPAT	18.16	13.45	0.56	0.49	0.54	0.60	1.07	1.37	1.86	0.27	0.51
Altman Z-Score	1.55	1.62	4.71	4.74	4.68	4.24	4.06	3.50	3.71	4.35	4.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.39	2.24	2.36	2.22	2.27	2.03	2.12	2.22	2.22	2.01	1.93
Quick Ratio	0.94	1.08	1.42	1.21	1.12	1.16	1.25	1.16	1.06	1.08	1.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,098	-1,113	26	35	18	-76	-72	-86	-112	21	12
Operating Cash Flow to CapEx	-109.21%	0.00%	744.59%	438.81%	40.36%	299.21%	878.79%	471.69%	41.89%	353.55%	923.02%
Free Cash Flow to Firm to Interest Expense	-77.39	-62.88	30.18	37.32	16.51	-48.54	-35.01	-38.49	-49.78	29.32	17.13
Operating Cash Flow to Interest Expense	-0.88	0.31	52.83	34.83	3.61	28.43	31.00	15.74	1.39	67.76	71.46
Operating Cash Flow Less CapEx to Interest Expense	-1.69	0.38	45.74	26.89	-5.33	18.93	27.47	12.40	-1.93	48.60	63.72
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.95	0.81	1.26	1.33	1.35	1.45	1.44	1.49	1.57	1.69	1.65
Accounts Receivable Turnover	11.77	8.66	11.77	12.15	13.45	11.70	11.11	11.00	13.22	11.96	11.61
Inventory Turnover	5.63	5.21	7.95	7.65	7.06	7.80	7.21	7.43	7.76	8.93	8.11
Fixed Asset Turnover	4.46	3.91	4.34	4.44	4.47	5.25	5.42	5.65	5.83	6.80	6.86
Accounts Payable Turnover	13.36	9.78	12.00	13.18	14.05	11.20	11.25	11.84	13.73	11.57	11.48
Days Sales Outstanding (DSO)	31.00	42.13	31.02	30.04	27.14	31.21	32.85	33.19	27.61	30.53	31.45
Days Inventory Outstanding (DIO)	64.84	70.11	45.93	47.71	51.68	46.82	50.66	49.12	47.02	40.87	45.00
Days Payable Outstanding (DPO)	27.32	37.31	30.41	27.70	25.97	32.58	32.44	30.84	26.58	31.53	31.79
Cash Conversion Cycle (CCC)	68.53	74.93	46.53	50.05	52.85	45.45	51.07	51.47	48.05	39.86	44.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,668	1,671	554	564	575	556	562	583	586	440	457
Invested Capital Turnover	1.28	1.15	1.94	1.92	1.91	2.27	2.24	2.21	2.30	2.80	2.70
Increase / (Decrease) in Invested Capital	1,093	1,115	-7.95	-19	-12	115	106	110	116	7.76	22
Enterprise Value (EV)	1,688	2,029	1,066	1,095	1,039	884	954	717	954	690	806
Market Capitalization	992	1,369	1,106	1,097	1,019	874	918	626	843	715	800
Book Value per Share	$20.57	$21.39	$17.94	$17.10	$16.91	$16.54	$15.96	$14.82	$14.36	$14.03	$13.51
Tangible Book Value per Share	($3.76)	($3.43)	$10.31	$9.45	$9.07	$8.75	$7.92	$6.82	$6.27	$7.91	$7.18
Total Capital	1,723	1,774	648	620	619	614	635	627	629	496	507
Total Debt	751	763	54	54	64	69	110	134	154	31	57
Total Long-Term Debt	725	737	51	52	62	66	107	132	152	30	55
Net Debt	696	660	-40	-1.97	20	10	36	91	111	-24	6.50
Capital Expenditures (CapEx)	11	-1.28	6.23	7.54	9.55	15	7.29	7.49	7.48	14	5.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)	289	261	82	91	100	83	81	104	106	87	99
Debt-free Net Working Capital (DFNWC)	345	364	176	148	144	141	154	147	149	142	149
Net Working Capital (NWC)	319	338	174	145	142	139	152	145	147	141	148
Net Nonoperating Expense (NNE)	10	16	-6.80	0.74	-0.23	12	1.48	1.81	1.65	3.90	8.13
Net Nonoperating Obligations (NNO)	696	660	-40	-1.97	20	10	36	91	111	-24	6.50
Total Depreciation and Amortization (D&A)	25	27	11	11	11	11	11	10	11	9.56	9.73
Debt-free, Cash-free Net Working Capital to Revenue	20.10%	20.44%	7.61%	8.31%	8.99%	7.33%	7.11%	8.89%	8.68%	7.10%	8.19%
Debt-free Net Working Capital to Revenue	23.96%	28.50%	16.30%	13.41%	13.00%	12.50%	13.52%	12.62%	12.22%	11.61%	12.33%
Net Working Capital to Revenue	22.16%	26.48%	16.05%	13.17%	12.78%	12.29%	13.32%	12.43%	12.05%	11.53%	12.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.32)	($0.52)	$0.77	$0.47	$0.19	$0.83	$0.97	$0.65	$0.06	$0.74	$0.79
Adjusted Weighted Average Basic Shares Outstanding	47.02M	36.42M	32.88M	32.87M	32.83M	32.82M	32.72M	32.86M	32.95M	33.05M	33.00M
Adjusted Diluted Earnings per Share	($0.32)	($0.52)	$0.77	$0.46	$0.19	$0.83	$0.96	$0.65	$0.06	$0.74	$0.78
Adjusted Weighted Average Diluted Shares Outstanding	47.02M	36.65M	33.11M	33.10M	33.04M	33.03M	32.92M	33.02M	33.14M	33.21M	33.17M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.23M	47.26M	47.25M	33.11M	33.10M	33.00M	32.99M	32.95M	33.24M	33.13M	66.26M
Normalized Net Operating Profit after Tax (NOPAT)	0.65	1.98	19	16	6.02	28	33	23	3.56	20	24
Normalized NOPAT Margin	0.16%	0.40%	6.62%	6.05%	2.52%	9.36%	11.07%	8.53%	1.36%	6.50%	7.35%
Pre Tax Income Margin	-4.98%	-3.56%	11.43%	7.40%	2.86%	10.77%	11.95%	9.89%	0.90%	9.12%	10.40%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.41	0.16	37.49	21.72	7.41	25.24	18.31	13.07	2.05	40.24	47.56
NOPAT to Interest Expense	-0.34	0.11	21.13	16.96	5.64	25.24	16.04	10.39	1.58	40.24	47.01
EBIT Less CapEx to Interest Expense	-1.21	0.23	30.39	13.79	-1.53	15.74	14.78	9.74	-1.27	21.07	39.82
NOPAT Less CapEx to Interest Expense	-1.15	0.18	14.03	9.03	-3.31	15.74	12.51	7.05	-1.74	21.07	39.27
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	110.18%	36.21%	14.30%	13.15%	12.23%	12.90%	13.33%	14.41%	13.51%	12.00%	12.63%
Augmented Payout Ratio	141.19%	36.21%	14.30%	13.15%	18.67%	19.67%	20.34%	28.76%	21.86%	19.47%	26.87%

Frequently Asked Questions About Quanex Building Products' Financials

When does Quanex Building Products's fiscal year end?

According to the most recent income statement we have on file, Quanex Building Products' financial year ends in October. Their financial year 2024 ended on October 31, 2024.

How has Quanex Building Products' net income changed over the last 10 years?

Quanex Building Products' net income appears to be on an upward trend, with a most recent value of $33.06 million in 2024, rising from $29.23 million in 2014. The previous period was $82.50 million in 2023. View Quanex Building Products' forecast to see where analysts expect Quanex Building Products to go next.

What is Quanex Building Products's operating income?

Quanex Building Products's total operating income in 2024 was $54.83 million, based on the following breakdown:

Total Gross Profit: $305.62 million
Total Operating Expenses: $250.80 million

How has Quanex Building Products revenue changed over the last 10 years?

Over the last 10 years, Quanex Building Products' total revenue changed from $595.38 million in 2014 to $1.28 billion in 2024, a change of 114.6%.

How much debt does Quanex Building Products have?

Quanex Building Products' total liabilities were at $1.31 billion at the end of 2024, a 358.4% increase from 2023, and a 1,260.8% increase since 2014.

How much cash does Quanex Building Products have?

In the past 10 years, Quanex Building Products' cash and equivalents has ranged from $17.46 million in 2017 to $120.38 million in 2014, and is currently $97.74 million as of their latest financial filing in 2024.

How has Quanex Building Products' book value per share changed over the last 10 years?

Over the last 10 years, Quanex Building Products' book value per share changed from 11.21 in 2014 to 21.39 in 2024, a change of 90.7%.

Related Companies

This page (NYSE:NX) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quanex Building Products (NX) Financials

Frequently Asked Questions About Quanex Building Products' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quanex Building Products (NX) Financials

Annual Income Statements for Quanex Building Products

Quarterly Income Statements for Quanex Building Products

Annual Cash Flow Statements for Quanex Building Products

Quarterly Cash Flow Statements for Quanex Building Products

Annual Balance Sheets for Quanex Building Products

Quarterly Balance Sheets for Quanex Building Products

Annual Metrics And Ratios for Quanex Building Products

Quarterly Metrics And Ratios for Quanex Building Products

Frequently Asked Questions About Quanex Building Products' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools